DNDN
DNDN Articles
(ASD) American Standard is reaffirming guidance.(AT) Alltel agreed to a $27.5 Billion buyout offer, or $71.50 per share.(CATT) Catapult believes it will miss its earnings estimates for the...
Published:
At about 5:20 this morning after rolling the calendar a day over to see the notes, something stood out like a sore thumb: DENDREON DO OR DIE DATE! The truth is that the May 15 date was on the...
Published:
Last Updated:
(AAPL) Apple’s talks about the Beatles are reportedly close to being settled.(ALL) Allstate is going to stop selling homeowners insurance policies in California.(ALU) Alcatel-Lucent earnings came...
Published:
Dendreon hosted a painful conference call today, and despite management answering most questions you could hear some frustration and disappointment out of management. The FDA has requested...
Published:
Stock Tickers: CSCO, DNDN, CMGI, IBM, ISIS, RTP, FWLT, MVSN, TXN, ERTS So far this is turning out to be an interesting day, despite what looks to be very mixed and dull markets ahead of a Fed meeting...
Published:
Dendreon (DNDN-NASDAQ) has already been noted as a bust this morning by us and by everyone else. Even the Sub-Saharan Africa nations have noticed it, and this 10-point drop in the stock may...
Published:
Dendreon Corporation (DNDN-NASDAQ) was hammered this morning. It received a Complete Response Letter from the FDA that is the equivalent of an "approvable letter" with a request for additional...
Published:
Last Updated:
A.G.Edwards has initiated the recently volatile and controversial Dendreon (DNDN-NASDAQ) with a Hold/Speculative rating. The summary points are that it is starting the biotech as a Hold rated...
Published:
Last Updated:
Dendreon’s short interest actually grew again in April from 26.4 million shares in March to 33.9 million shares. The short interest was listed as 16.8 million shares in February. ...
Published:
Last Updated:
Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have been very active all on its own, but since Dendreon (DNDN-NASDAQ) made its...
Published:
Last Updated:
Cell Genesys, Inc. (CEGE-NASDAQ) has done what many small biotechs do that are in need of cash: sell shares in a private placement "PIPE" after a sharp stock run-up. It has entered...
Published:
Cramer in a question from a student tonight on CNBC’s MAD MONEY was actually asked about the recently wild Dendreon (DNDN-NASDAQ). What he said was that he thinks it can still go up and...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.